Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 512023생성일: 2026년 10월 27일
Citric Acid → N-(methylsulfonyl)-4-{[6-(trifluoromethyl)pyridin-3-yl]methoxy}benzamide formate salt
https://huagongshe.com/reaction/512023
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Citric Acid | HCID 311 | — |
| 반응물 | Lithium Hydroxide | HCID 3939 | — |
| 반응물 | Methylparaben | HCID 7456 | — |
| 반응물 | Triphenylphosphine | HCID 11776 | — |
| 반응물 | Methanesulfonamide | HCID 72879 | — |
| 반응물 | 1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride | HCID 2723939 | — |
| 반응물 | 6-(Trifluoromethyl)pyridine-3-methanol | HCID 3613895 | — |
| 촉매 | 4-(Dimethylamino)pyridine | HCID 14284 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | N-(methylsulfonyl)-4-{[6-(trifluoromethyl)pyridin-3-yl]methoxy}benzamide formate salt | HCID 86682565 | — |
반응 단계
To methyl 4-hydroxybenzoate (22.8 mg, 0.15 mmol) and [6-(trifluoromethyl)pyridin-3-yl]methanol (22.1 mg, 0.125 mmol) in DCM (1 mL) was added N,N,N′N′-tetramethylazodicarboxylate (43 mg) and polymer supported triphenylphosphine (3 mmol/g, 125 mg, 0.375 mmol). The reaction was shaken at 30° C. for 16 hours, filtered, diluted with aqueous citric acid solution (2.5%, 1 mL) and extracted with DCM (3×1 mL). The combined organics were concentrated in vacuo. The resulting crude residue was dissolved in THF (0.625 mL), treated with aqueous lithium hydroxide solution (2 M, 0.625 mL, 1.25 mmol) and the mixture shaken at 50° C. for 16 hours. The solvent was removed in vacuo, the residue dissolved in aqueous citric acid solution (4 M, 0.4 mL, 1.6 mmol) and extracted with EtOAc (3×1 mL), dried over sodium sulfate, filtered and the solvent removed in vacuo. To the resulting crude residue DCM (1 mL), methanesulphonamide (12 mg, 0.126 mmol), 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (EDCI) (72 mg, 0.377 mmol) and DMAP (23 mg, 0.188 mmol) was added and the mixture was shaken at 30° C. for 16 hours. The solvent was removed under reduced pressure and the resulting crude product was purified by preparative HPLC to afford the title compound.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US09102621B2 |
|---|
| 출처 데이터셋 | uspto-grants-2015_08 |
|---|
| ORD ID | ord-0fbba13ecb0e4828b4193f515b156922 |
|---|
| 출처 메모 | uspto-grants-2015_08 |
|---|